Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-14 Purchase | 2022-12-16 1:29 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 38,032 | $3.9956 | $151,962 | 5,955,852 (Indirect Direct) | View |
| 2022-12-15 Purchase(A) | 2022-12-16 10:17 am | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 300,488 | $1.1002 | $330,597 | 30,890,595 (Indirect Direct) | View |
| 2022-12-15 Purchase | 2022-12-15 4:22 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 300,488 | $1.1002 | $330,597 | 30,880,595 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-08 5:09 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 69,196 | $4.0281 | $278,729 | 5,917,820 (Indirect Direct) | View |
| 2022-12-06 Purchase | 2022-12-08 4:46 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 178,768 | $1.1907 | $212,867 | 30,590,107 (Indirect Direct) | View |
| 2022-11-16 Purchase | 2022-11-18 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 133,185 | $1.3928 | $185,498 | 30,411,339 (Indirect Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 4:03 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 34,100 | $4.6225 | $157,628 | 5,848,624 (Indirect Direct) | View |
| 2022-08-02 Purchase | 2022-08-04 4:54 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 100,000 | $4.6749 | $467,486 | 5,814,524 (Indirect Direct) | View |
| 2022-06-06 Purchase | 2022-06-08 4:06 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 42,970 | $5.1024 | $219,252 | 5,714,524 (Indirect Direct) | View |
| 2022-02-24 Purchase | 2022-02-28 4:43 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 55,030 | $4.4465 | $244,690 | 5,671,554 (Indirect Direct) | View |
| 2021-12-21 Purchase | 2021-12-23 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 7,731,573 | $4.1856 | $32,361,272 | 30,278,154 (Indirect Direct) | View |
| 2021-12-21 Sale | 2021-12-23 4:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 7,731,573 | $4.1856 | $32,361,272 | 30,278,154 (Indirect Direct) | View |
| 2021-12-17 Purchase | 2021-12-20 4:11 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 53,251 | $5.5703 | $296,624 | 5,616,524 (Indirect Direct) | View |
| 2021-08-30 Sale | 2021-09-01 4:46 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 420,285 | $6.9487 | $2,920,427 | 5,944,901 (Indirect Direct) | View |
| 2021-08-02 Purchase | 2021-08-04 3:55 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 25,200 | $7.9076 | $199,271 | 5,563,273 (Indirect Direct) | View |
| 2021-01-06 Purchase | 2021-01-07 09:49 am | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,750 | $2.851 | $999,988 | 6,365,186 (Indirect Direct) | View |
| 2020-12-24 Purchase | 2020-12-28 10:30 am | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 51,195 | $1.9513 | $99,897 | 6,014,436 (Indirect Direct) | View |
| 2020-12-02 Purchase | 2020-12-02 4:22 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 53,900 | $1.949 | $105,051 | 5,963,241 (Indirect Direct) | View |
| 2020-11-24 Purchase | 2020-11-24 4:46 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 62,000 | $1.6459 | $102,046 | 5,909,341 (Indirect Direct) | View |
| 2020-11-16 Purchase | 2020-11-16 4:36 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 62,000 | $1.6924 | $104,929 | 5,847,341 (Indirect Direct) | View |
| 2020-08-12 Purchase(A) | 2020-08-13 4:28 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,000 | $1.6334 | $571,680 | 5,785,341 (Indirect Direct) | View |
| 2020-08-12 Purchase | 2020-08-13 4:01 pm | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 350,000 | $1.6334 | $571,680 | 4,125,000 (Indirect Direct) | View |
| 2020-05-14 Purchase | 2020-05-18 4:37 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 5,000 | $7.4293 | $37,147 | 5,538,073 (Indirect Direct) | View |
| 2020-05-07 Purchase | 2020-05-11 4:29 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 8,810 | $8.1457 | $71,764 | 5,533,073 (Indirect Direct) | View |
| 2020-05-04 Purchase | 2020-05-06 4:33 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 11,190 | $8.0116 | $89,649 | 5,524,263 (Indirect Direct) | View |
| 2020-03-13 Purchase | 2020-03-17 4:45 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 50,000 | $5.5012 | $275,060 | 5,513,073 (Indirect Direct) | View |
| 2020-02-18 Purchase | 2020-02-20 12:16 pm | ULTRALIFE CORP | ULBI | WHITMORE BRADFORD T Director 10% Owner | 100,000 | $7.2372 | $723,721 | 5,463,073 (Indirect Direct) | View |
| 2019-05-13 Purchase | 2019-05-15 5:28 pm | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 4,189,000 | $0.4 | $1,675,600 | 20,182,599 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-07 Conversion | 2021-05-11 4:37 pm | N/A N/A | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 12,114,666 | $0.2 | 30,278,154 (Direct) | View |
| 2020-09-29 Other | 2020-10-01 4:34 pm | N/A N/A | NANOPHASE TECHNOLOGIES Corp | NANX | WHITMORE BRADFORD T 10% Owner | 2,433,300 | $0 | 27,049,199 (Direct) | View |
| 2019-11-26 Ownership | 2019-11-26 12:54 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | WHITMORE BRADFORD T 10% Owner | 0 | $0 | 5,435,341 (Direct) | View |